Cannabis and Liver Disease

The human liver is the largest organ in the body.  It has many functions as well as afflictions.  Some are inherited and others are through abuse or viruses.  There are many kinds of liver diseases. Viruses cause some of them, like hepatitis A, hepatitis B and hepatitis C. Others can be the result of drugs, poisons or drinking too much alcohol. If the liver forms scar tissue because of an illness, it’s called cirrhosis.  Jaundice, or yellowing of the skin, can be one sign of liver disease.  Like other parts of your body, cancer can affect the liver. You could also inherit a liver disease such as hemochromatosis.  Below are studies that show the interaction of cannabis compounds and the liver.  Please feel free to share ~ Cherry Girl

The Endocannabinoid System As A Novel Target For the Treatment of Liver Fibrosis
We have recently demonstrated that CB1 and CB2 receptors display opposite effects in the regulation of liver fibrogenesis during chronic liver injury. Indeed, both receptors are up-regulated in the liver of cirrhotic patients, and expressed in liver fibrogenic cells. Moreover, CB1 receptors are profibrogenic and accordingly, the CB1 antagonist rimonabant reduces fibrosis progression in three experimental models. In keeping with these results, daily cannabis smoking is a risk factor for fibrosis progression in patients with chronic hepatitis C. In contrast, CB2 display antifibrogenic effects, by a mechanism involving reduction of liver fibrogenic cell accumulation. These results may offer new perspectives for the treatment of liver fibrosis, combining CB2 agonist and CB1 antagonist therapy.

The Endocannabinoid System and Liver Diseases
The endocannabinoid system and liver diseases… molecules targeting the CB(1) and CB(2) receptors may represent potential therapeutic agents for the treatment of liver diseases. At present, the CB(1) antagonists represent the most attractive pharmaceutical tool to resolve fat accumulation in patients with non-alcoholic fatty liver disease and to treat patients with cirrhosis, as they may slow the progression of fibrosis and attenuate the cardiovascular alterations associated with the advanced stage of the disease.

Endocannabinoids in Liver Disease
Marijuana has been used for its psychoactive and medicinal properties for millennia. As other plant-derived substances, marijuana has been slow to yield its secrets, with insights into its mechanism of action beginning to emerge only during the last decades… Endocannabinoids are lipid mediators of the same cannabinoid (CB) receptors that mediate the effects of marijuana… Although the documented therapeutic potential of CB(1) blockade is limited by neuropsychiatric side effects, these may be mitigated by using novel, peripherally restricted CB(1) antagonists.

Endogenous Cannabinoids in Liver Disease: Many Darts For A Single Target
Endogenous cannabinoids are ubiquitous lipid-signaling molecules able to partially mimic the actions produced by Delta(9)-tetrahydrocannabinol, the compound responsible for most of the effects of marijuana… The endocannabinoid system is involved in the pathogenesis of the cardiovascular dysfunction occurring in advanced liver disease and also plays a role in the pathogenesis of portal hypertension and liver fibrosis… These findings indicate that the endocannabinoid system may open new avenues for the therapeutic regulation of fibrosis and portal hypertension in advanced liver disease.

Cannabinoid Receptors As New Targets of Antifibrosing Strategies During Chronic Liver Diseases
Cannabinoid receptors as new targets of antifibrosing strategies during chronic liver diseases… Chronic liver injury exposes the patient to liver fibrosis and its end stage, cirrhosis, is a major public health problem worldwide… prevailing causes of cirrhosis include chronic alcohol consumption, hepatitis C virus infection and non-alcoholic steatohepatitis…. the authors recently demonstrated that the endocannabinoid system shows promise as a novel target for antifibrotic therapy during chronic liver injury. Indeed, cannabinoid receptors CB1 and CB2 promote dual pro- and antifibrogenic effects, respectively. Therefore, endocannabinoid-based therapies, combining CB2 agonists and CB1 antagonists may open novel therapeutic perspectives for the treatment of chronic liver diseases.

CB1 Cannabinoid Receptor Antagonism: A New Strategy For the Treatment of Liver Fibrosis
Hepatic fibrosis, the common response associated with chronic liver diseases, ultimately leads to cirrhosis, a major public health problem worldwide.  Genetic or pharmacological inactivation of CB1 receptors decreased fibrogenesis by lowering hepatic transforming growth factor (TGF)-beta1 and reducing accumulation of fibrogenic cells in the liver after apoptosis and growth inhibition of hepatic myofibroblasts. In conclusion, our study shows that CB1 receptor antagonists hold promise for the treatment of liver fibrosis.

Role of Cannabinoids in Chronic Liver Diseases
The role of the endocannabinoid system in hepatic physiology and pathologic conditions has been studied recently. Unquestionably, influencing endocannabinoid signaling may have a beneficial effect on delaying or even reversing hepatic fibrosis.

CB2 Receptors As New Therapeutic Targets For Liver Diseases
phytocannabinoids have long been used for recreational and therapeutic purposes… studies have unravelled pleiotropic functions of CB2 receptors under physiological and pathological conditions, including acute and chronic liver diseases. Additional functions may soon arise… These findings may open novel therapeutic avenues, upon clinical development of CB2-specific molecules.

Beneficial Paracrine Effects of Cannabinoid Receptor 2 on Liver Injury and Regeneration
CONCLUSION: CB2 receptors reduce liver injury and promote liver regeneration following acute insult, via distinct paracrine mechanisms involving hepatic myofibroblasts. These results suggest that CB2 agonists display potent hepatoprotective (ability to prevent damage to the liver) properties, in addition to their antifibrogenic effects.

Cannabinoid Receptor Type I Modulates Alcohol-Induced Liver Fibrosis
CB1 expression is upregulated in human ALF (alcoholic liver fibrosis ) which is at least in part triggered by acetaldehyde (AA) and oxidative stress. Inhibition of CB1… or via genetic knock-out protects against alcoholic-induced fibrosis in vitro and in vivo….CB1 antagonists have been used in treating alcohol dependence without causing significant depression.

The Endocannabinoid System As A Key Mediator During Liver Diseases: New Insights and Therapeutic Openings
“The endocannabinoid system as a key mediator during liver diseases: new insights and therapeutic openings… hepatic cannabinoid receptor 2 (CB(2)) receptors display beneficial effects on alcoholic fatty liver, hepatic inflammation, liver injury, regeneration and fibrosis. Cannabinoid receptor 1 (CB(1)) receptors have been implicated in the pathogenesis of several lesions such as alcoholic and metabolic steatosis, liver fibrogenesis, or circulatory failure associated with cirrhosis… data obtained with peripherally restricted CB(1) antagonists give real hopes in the development of active CB(1) molecules devoid of central adverse effects.

Pathogenesis of Alcohol-Induced Liver Disease: Classical Concepts and Recent Advances
Alcoholic liver disease (ALD) is a primary consequence of heavy and prolonged drinking.  The observation that ALD and non-alcoholic steatohepatitis share common pathways and genetic polymorphisms suggests operation of parallel pathogenic mechanisms. Future research involving genomics, epigenomics, deep sequencing and non-coding regulatory elements holds promise to identify novel diagnostic and therapeutic targets for ALD. There is also a need for adequate animal models to study pathogenic mechanisms at the molecular level and targeted therapy.

The Role of the Cannabinoid System in the Pathogenesis and Treatment of Alcohol Dependence
The lack of satisfactory results of alcohol dependence treatment force us to search for new directions of research.  SR141716 (rimonabant), a CB1 receptor antagonist, significantly lowers voluntary alcohol intake and motivation for its consumption in various experimental studies. Very encouraging results of preclinical studies were not completely confirmed in the clinical studies. However, further clinical studies are still necessary.


13 thoughts on “Cannabis and Liver Disease

  1. Pingback: Central Nervous Disease and Cannabis | Cherry Girl

  2. Pingback: Cannabis: Your Heart Hero | Cherry Girl

  3. Pingback: Save Your Ass, Smoke Some Grass | Cherry Girl

  4. Pingback: Cannabis Has Cancer In The Cross-Hairs. Utilizing The Endocannabinoid System To Kill Cancer | Cherry Girl

  5. Pingback: Ganja For Your Guts: How Cannabis Can Help IBS | Cherry Girl

  6. Hello and thanks for all the great information. I hope you can answer my questions…….re:…cb1 agonist, cb2 antagonist….my brother has Liver failure and Hep C. I read the article and im trying to translate it for practical use. I cooked up some high cbd bud and it didn’t turn into oil. I pulled it up into the syringe and it turned hard. A friend told me that I created “shatter”. So I read up 9th that and saw somewhere that I may have burned off the turned and maybey some of the medicine that heals… that true? Most importantly where in the mix is the cb1 agonist and the cbd antagonist….i went to great lengths to grow from seed high cbd plants with a 1:1 ratio….but not not clear if my mix could actually cause more damage to brothers liver….which compound contains cb1 agonist? Is it in the thc? I. The cbd? Same for cb2 antagonist…where does it occur in the plant?….Now I’m concerned that by giving get him the shatter it 1. May not even have medicine cuz I may have burned it off…2. It may be harming him because it has the wrong Cbd or cb2 …can’t quite figure out which one is bad for his liver…we are in the hospital now. They just pumped 5 liters of fluid out…when i get him home not sure if i should discontinue the shatter…..I would really appreciate any information you can share…I’m not a scientist so need it broken down to practical terms….

    h order to use it I have to heats it up 8th hot water and squeeze a bit out.

    • One of the biggest reasons why cannabis fails to work as desired is the compounds found within the strain/s used are not targeted/desirable for the illness. With more and more strains being mapped and bred we can hopefully have a future where this important information is factored into treatment. For your case you would need to find the compounds that work for the illness, find a source and then properly extract. I am fortunate enough to have access to a legal dispensary that offers oil. I am not an expert at all in that field but there are plenty of sources that will walk you through how to. I would also suggest reaching out to the medical community in the nearest state that offers it and see if you can get any information from them directly. By going to a legal medical source you will hopefully avoid pitfalls that make the end product more harmful than necessary. It also can be a dangerous process if not doing properly. One more reason I advocate for legalization across the country. Patients should not be doing this on their own without proper guidance. I hope that this has helped in some small way and please let me know if you need any further help. I wish you all the best and good health.

  7. hello there. my father 78 years old has liver cirrhosis and would like to try marijuana.hopefully his liver can still function again

  8. My son has non alcoholic fatty liver disease which has caused some cirrhosis of the liver. CBD is helping him. The doctors said that he has had the fatty liver since birth, but the cirrhosis just shown up in the last couple of years, causing painful and debilitating health symptoms due to fluid bile up and jaundice which caused him to lose his employment. We started him on water soluble Biocbdplus last year and noticed that it cleared up the jaundice effects in a couple of days and after a while began to reduce some pain. His doctor said to stay with CBD because it seemed to be working well. – Pam

  9. CBD is working for my son. My son’s doctor reported that his end of October evaluation had shown no future deterioration of his liver and that minor healing of scar tissue is still being noticed. He recommended we keep up with what we were doing and that this slow and steady improvement is keeping him off of the liver replacement list. This positive report shows us that the daily regiment of water soluble BioCBDplus capsules is working. – Haas

Leave a Reply to Pam Cancel reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s